This is the second volume in a fourvolume series aimed at guiding the pharmaceutical industry toward sustainability. After analyzing and exposing some of the backward and illconceived notions that guide the present state of the industry this volume presents key theories and new groundbreaking solutions for rethinking the processes involved in the engineering of pharmaceuticals and offers a fundamental paradigm shift. The 4 volumes in this ambitious project are Volume 1 Practice Analysis and